Fundraising Fox

Convelo Therapeutics

Cleveland, US · Delaware corporation · 3 known investors

convelotx.com ↗

Convelo Therapeutics develops remyelination-enhancing therapies targeting multiple sclerosis by activating oligodendrocytes to repair nerve damage in the central nervous system. The company aims to enable myelin regeneration and restore function for MS patients.

BiotechDigital HealthHealthtechMedical Devicesin /convelotx@ConveloTx

Founders & leadership

PT
Paul TesarCo-founder, Professor
DA
Drew AdamsCo-founder, Professor
DR
Derrick RossiCEO
RR
Ronald RichardDirector
BS
Bill SanfordDirector
SL
Steven LandauExecutive Officer

Investors · 3

CWRU Technology VenturesCleveland · $50K – $250K
JobsOhio VenturesColumbus
Jumpstart VenturesCleveland · $500K – $2M

Reported raises · per SEC filings

Form D private placements
▶$10.8MraisedDec 2022 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Drew AdamsDirector
  • Ronald RichardDirector
  • Paul TesarDirector
  • Derrick RossiDirector
  • Bill SanfordDirector
Offering amount
$12M
Amount sold
$10.8M
Minimum investment
$50K
Proceeds to insiders
$400K
First sale
Dec 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2MraisedDec 2017 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Drew AdamsDirector
  • Paul TesarDirector
  • Ronald RichardDirector
  • Bill SanfordDirector
  • Derrick RossiExecutive Officer, Director
  • Steven LandauExecutive Officer
Offering amount
$15M
Amount sold
$2M
First sale
Nov 2017
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.